Yujie Feng Selected Research

Yujie Feng Research Topics

Disease

22	Neoplasms (Cancer) 04/2024 - 03/2015
9	Insulin Resistance 02/2024 - 10/2015
7	Inflammation (Inflammations) 02/2024 - 10/2017
7	Body Weight (Weight, Body) 12/2022 - 10/2015
6	Neoplasm Metastasis (Metastasis) 03/2024 - 01/2018
6	Cholangiocarcinoma 03/2023 - 01/2018
4	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 10/2018
2	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 11/2019
2	Wounds and Injuries (Trauma) 11/2023 - 08/2023
2	Bites and Stings (Sting) 10/2022 - 07/2021
1	Diverticulum 04/2024
1	Pancreatitis 03/2024
1	Vitiligo 03/2024
1	Arthritis (Polyarthritis) 03/2024
1	Acute Kidney Injury (Acute Renal Failure) 03/2024
1	Cholangitis 03/2024
1	Granuloma 03/2024
1	Myositis (Idiopathic Inflammatory Myopathies) 03/2024
1	Rheumatic Diseases (Rheumatism) 03/2024
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 03/2024
1	Glucose Metabolism Disorders 02/2024
1	Osteoporosis 08/2023
1	Disease Progression 03/2023
1	Klatskin Tumor 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 05/2022
1	Colonic Neoplasms (Colon Cancer) 05/2022
1	Immune System Diseases (Immune Disorders) 03/2022
1	Autoimmune Diseases (Autoimmune Disease) 03/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2022
1	Starvation 02/2022
1	Glioma (Gliomas) 01/2022
1	Breast Neoplasms (Breast Cancer) 12/2021

Drug/Important Bio-Agent (IBA)

7	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 10/2015
6	Biomarkers (Surrogate Marker)IBA 03/2024 - 10/2019
6	Long Noncoding RNAIBA 09/2023 - 10/2018
4	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2022 - 10/2015
3	CytokinesIBA 03/2022 - 09/2016
3	HydrogelsIBA 12/2021 - 01/2011
2	CollagenIBA 03/2024 - 03/2008
2	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2021
2	p38 Mitogen-Activated Protein KinasesIBA 02/2024 - 09/2016
2	CarbonIBA 08/2023 - 07/2022
2	CarbohydratesIBA 03/2023 - 01/2023
2	Carcinoembryonic AntigenIBA 03/2023 - 01/2023
2	AlbuminsIBA 03/2023 - 01/2020
2	AntigensIBA 03/2023 - 01/2023
2	BilirubinIBA 03/2023 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 07/2021
2	Hepatitis B e AntigensIBA 07/2021 - 01/2021
2	Small Interfering RNA (siRNA)IBA 02/2021 - 10/2019
2	ParaffinIBA 01/2020 - 12/2019
2	Insulin Receptor Substrate ProteinsIBA 01/2020 - 01/2018
2	MicroRNAs (MicroRNA)IBA 01/2017 - 01/2017
1	GadoliniumIBA 04/2024
1	pembrolizumabIBA 03/2024
1	Immune Checkpoint InhibitorsIBA 03/2024
1	NivolumabIBA 03/2024
1	Hydroxyproline (4 Hydroxyproline)IBA 03/2024
1	Docetaxel (Taxotere)FDA Link 03/2024
1	Alanine Transaminase (SGPT)IBA 03/2024
1	IpilimumabIBA 03/2024
1	ProteomeIBA 03/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2024
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 12/2023
1	SilverIBA 11/2023
1	ZincIBA 11/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2023
1	Risedronic Acid (Actonel)FDA LinkGeneric 08/2023
1	Ibandronic Acid (Boniva)FDA Link 08/2023
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 08/2023
1	Diphosphonates (Bisphosphonates)IBA 08/2023
1	IonsIBA 08/2023
1	CalciumIBA 08/2023
1	Egtazic Acid (EGTA)IBA 08/2023
1	Alkaline PhosphataseIBA 03/2023
1	Hemoglobins (Hemoglobin)IBA 03/2023
1	TransferasesIBA 03/2023
1	6-propylchromone-2-carboxylic acid (PCCA)IBA 01/2023
1	HDL LipoproteinsIBA 01/2023
1	Poly I-CIBA 12/2022
1	Interferon Type IIBA 10/2022
1	Sorafenib (BAY 43-9006)FDA Link 10/2022
1	Insulin ReceptorIBA 07/2022
1	apatinibIBA 05/2022
1	AntibodiesIBA 03/2022
1	Interleukin-17 (Interleukin 17)IBA 03/2022
1	HydrogenIBA 02/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	CateninsIBA 01/2022
1	Antisense RNA (Anti-Sense RNA)IBA 12/2021
1	Conditioned Culture MediaIBA 12/2021
1	5-ethynyl-2'-deoxyuridineIBA 12/2021
1	Emodin (Archin)IBA 12/2021

Therapy/Procedure

5	Oral Administration 04/2020 - 10/2015
4	Drug Therapy (Chemotherapy) 04/2024 - 01/2018
3	Therapeutics 03/2024 - 01/2021
1	Endoscopic Sphincterotomy 04/2024
1	Immunotherapy 03/2024
1	Hepatectomy 03/2023
1	Biological Therapy 03/2022